These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22512618)

  • 21. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
    Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
    Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors.
    Yamada M; Yura T; Morimoto M; Harada T; Yamada K; Honma Y; Kinoshita M; Sugiura M
    J Med Chem; 1996 Jan; 39(2):596-604. PubMed ID: 8558532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease.
    Kim DK; Lee KH; Kim SJ; Kim SJ; Lee SJ; Park CH; Kim BT; Song GS; Moon BS; Ryu SY
    J Pharmacol Exp Ther; 2019 Jun; 369(3):318-327. PubMed ID: 30894456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinamide derivatives as a new class of gastric H+/K(+)-ATPase inhibitors. 1. Synthesis and structure-activity relationships of N-substituted 2-(benzhydryl- and benzylsulfinyl)nicotinamides.
    Terauchi H; Tanitame A; Tada K; Nakamura K; Seto Y; Nishikawa Y
    J Med Chem; 1997 Jan; 40(3):313-21. PubMed ID: 9022797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. tert-Butyl 1,5-bis(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-1,5-dioxopentan-2-ylcarbamate urea/thiourea derivatives as potent H+/K(+)-ATPase inhibitors.
    Sharma A; Suhas R; Chandana KV; Banu SH; Channe Gowda D
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4096-8. PubMed ID: 23756367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gedunin and photogedunin of Xylocarpus granatum show significant anti-secretory effects and protect the gastric mucosa of peptic ulcer in rats.
    Lakshmi V; Singh N; Shrivastva S; Mishra SK; Dharmani P; Mishra V; Palit G
    Phytomedicine; 2010 Jul; 17(8-9):569-74. PubMed ID: 19962286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction to "1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases.".
    J Pharmacol Exp Ther; 2016 Jul; 358(1):1-2. PubMed ID: 27278809
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
    Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
    Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of novel 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives as potent potassium-competitive acid blockers.
    Wang X; Xu Y; Zong Z; Cai J; Chen C; Zhang Q; Sun X; Li J
    Bioorg Med Chem; 2022 Jun; 64():116765. PubMed ID: 35477061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2'-piperidin)-1-ones as potassium-competitive acid blockers.
    Imaeda T; Ono K; Nakai K; Hori Y; Matsukawa J; Takagi T; Fujioka Y; Tarui N; Kondo M; Imanishi A; Inatomi N; Kajino M; Itoh F; Nishida H
    Bioorg Med Chem; 2017 Jul; 25(14):3719-3735. PubMed ID: 28522264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs).
    Arikawa Y; Hasuoka A; Nishida H; Hirase K; Inatomi N; Takagi T; Tarui N; Kawamoto M; Imanishi A; Itoh F; Kajino M
    Bioorg Med Chem Lett; 2015; 25(10):2037-40. PubMed ID: 25891103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on antiulcer agents. I. Synthesis and pharmacological properties of ethyl 2-[(1H-benzimidazol-2-yl)sulfinylmethyl]-4-dimethylamino-5- pyrimidinecarboxylate, a new H+/K(+)-ATPase inhibitor possessing mucosal protective activity.
    Terashima K; Shimamura H; Kawase A; Tanaka Y; Uenishi K; Kimura I; Ishizuka Y; Sato M
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):166-8. PubMed ID: 7895305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
    J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase.
    Bratton LD; Auerbach B; Choi C; Dillon L; Hanselman JC; Larsen SD; Lu G; Olsen K; Pfefferkorn JA; Robertson A; Sekerke C; Trivedi BK; Unangst PC
    Bioorg Med Chem; 2007 Aug; 15(16):5576-89. PubMed ID: 17560788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
    Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
    Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
    J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
    Smolka AJ; Goldenring JR; Gupta S; Hammond CE
    BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.